Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Tregs in fibrosis: To know your enemy, you must become your enemy.

Bal SM, Stadhouders R.

Sci Immunol. 2019 Sep 6;4(39). pii: eaay1160. doi: 10.1126/sciimmunol.aay1160. Review.

PMID:
31492710
2.

Correction: KLRG1 and NKp46 discriminate subpopulations of human CD117+CRTH2- ILCs biased toward ILC2 or ILC3.

Nagasawa M, Heesters BA, Kradolfer CMA, Krabbendam L, Martinez-Gonzalez I, de Bruijn MJW, Golebski K, Hendriks RW, Stadhouders R, Spits H, Bal SM.

J Exp Med. 2019 Sep 2;216(9):2221-2222. doi: 10.1084/jem.2019049007302019c. Epub 2019 Aug 6. No abstract available.

3.

KLRG1 and NKp46 discriminate subpopulations of human CD117+CRTH2- ILCs biased toward ILC2 or ILC3.

Nagasawa M, Heesters BA, Kradolfer CMA, Krabbendam L, Martinez-Gonzalez I, de Bruijn MJW, Golebski K, Hendriks RW, Stadhouders R, Spits H, Bal SM.

J Exp Med. 2019 Aug 5;216(8):1762-1776. doi: 10.1084/jem.20190490. Epub 2019 Jun 14. Erratum in: J Exp Med. 2019 Aug 6;:.

4.

IL-1β, IL-23, and TGF-β drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation.

Golebski K, Ros XR, Nagasawa M, van Tol S, Heesters BA, Aglmous H, Kradolfer CMA, Shikhagaie MM, Seys S, Hellings PW, van Drunen CM, Fokkens WJ, Spits H, Bal SM.

Nat Commun. 2019 May 14;10(1):2162. doi: 10.1038/s41467-019-09883-7.

5.

Eosinophils capture viruses, a capacity that is defective in asthma.

Sabogal Piñeros YS, Bal SM, Dijkhuis A, Majoor CJ, Dierdorp BS, Dekker T, Hoefsmit EP, Bonta PI, Picavet D, van der Wel NN, Koenderman L, Sterk PJ, Ravanetti L, Lutter R.

Allergy. 2019 Apr 1. doi: 10.1111/all.13802. [Epub ahead of print]

PMID:
30934128
6.

Do eosinophils contribute to oxidative stress in mild asthma?

de Groot LES, Sabogal Piñeros YS, Bal SM, van de Pol MA, Hamann J, Sterk PJ, Kulik W, Lutter R.

Clin Exp Allergy. 2019 Jun;49(6):929-931. doi: 10.1111/cea.13389. Epub 2019 Apr 9. No abstract available.

PMID:
30891863
7.

Interferon-induced epithelial response to rhinovirus 16 in asthma relates to inflammation and FEV1.

Ravi A, Koster J, Dijkhuis A, Bal SM, Sabogal Piñeros YS, Bonta PI, Majoor CJ, Sterk PJ, Lutter R.

J Allergy Clin Immunol. 2019 Jan;143(1):442-447.e10. doi: 10.1016/j.jaci.2018.09.016. Epub 2018 Oct 5. No abstract available.

PMID:
30296526
8.

New insights into the function, development, and plasticity of type 2 innate lymphoid cells.

Krabbendam L, Bal SM, Spits H, Golebski K.

Immunol Rev. 2018 Nov;286(1):74-85. doi: 10.1111/imr.12708. Review.

PMID:
30294969
9.

Anti-IL-5 in Mild Asthma Alters Rhinovirus-induced Macrophage, B-Cell, and Neutrophil Responses (MATERIAL). A Placebo-controlled, Double-Blind Study.

Sabogal Piñeros YS, Bal SM, van de Pol MA, Dierdorp BS, Dekker T, Dijkhuis A, Brinkman P, van der Sluijs KF, Zwinderman AH, Majoor CJ, Bonta PI, Ravanetti L, Sterk PJ, Lutter R.

Am J Respir Crit Care Med. 2019 Feb 15;199(4):508-517. doi: 10.1164/rccm.201803-0461OC.

PMID:
30192638
10.

Isolation of Human Innate Lymphoid Cells.

Krabbendam L, Nagasawa M, Spits H, Bal SM.

Curr Protoc Immunol. 2018 Jun 29:e55. doi: 10.1002/cpim.55. [Epub ahead of print]

PMID:
29957859
11.

Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications.

Kortekaas Krohn I, Shikhagaie MM, Golebski K, Bernink JH, Breynaert C, Creyns B, Diamant Z, Fokkens WJ, Gevaert P, Hellings P, Hendriks RW, Klimek L, Mjösberg J, Morita H, Ogg GS, O'Mahony L, Schwarze J, Seys SF, Shamji MH, Bal SM.

Allergy. 2018 Apr;73(4):837-850. doi: 10.1111/all.13340. Epub 2017 Nov 22. Review.

PMID:
29069535
12.

The role of innate lymphoid cells in airway inflammation: evolving paradigms.

Kortekaas Krohn I, Bal SM, Golebski K.

Curr Opin Pulm Med. 2018 Jan;24(1):11-17. doi: 10.1097/MCP.0000000000000435. Review.

PMID:
29036021
13.

Neuropilin-1 Is Expressed on Lymphoid Tissue Residing LTi-like Group 3 Innate Lymphoid Cells and Associated with Ectopic Lymphoid Aggregates.

Shikhagaie MM, Björklund ÅK, Mjösberg J, Erjefält JS, Cornelissen AS, Ros XR, Bal SM, Koning JJ, Mebius RE, Mori M, Bruchard M, Blom B, Spits H.

Cell Rep. 2017 Feb 14;18(7):1761-1773. doi: 10.1016/j.celrep.2017.01.063.

14.

Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases.

Shikhagaie MM, Germar K, Bal SM, Ros XR, Spits H.

Nat Rev Rheumatol. 2017 Mar;13(3):164-173. doi: 10.1038/nrrheum.2016.218. Epub 2017 Feb 2. Review.

PMID:
28148916
15.

An early innate response underlies severe influenza-induced exacerbations of asthma in a novel steroid-insensitive and anti-IL-5-responsive mouse model.

Ravanetti L, Dijkhuis A, Sabogal Pineros YS, Bal SM, Dierdorp BS, Dekker T, Logiantara A, Adcock IM, Rao NL, Boon L, Villetti G, Sterk PJ, Facchinetti F, Lutter R; U-BIOPRED Study Group.

Allergy. 2017 May;72(5):737-753. doi: 10.1111/all.13057. Epub 2016 Nov 10.

16.

IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs.

Bal SM, Bernink JH, Nagasawa M, Groot J, Shikhagaie MM, Golebski K, van Drunen CM, Lutter R, Jonkers RE, Hombrink P, Bruchard M, Villaudy J, Munneke JM, Fokkens W, Erjefält JS, Spits H, Ros XR.

Nat Immunol. 2016 Jun;17(6):636-45. doi: 10.1038/ni.3444. Epub 2016 Apr 25.

PMID:
27111145
17.

The caspase inhibitor zVAD increases lung inflammation in pneumovirus infection in mice.

van den Berg E, Bal SM, Kuipers MT, Matute-Bello G, Lutter R, Bos AP, van Woensel JB, Bem RA.

Physiol Rep. 2015 Mar;3(3). pii: e12332. doi: 10.14814/phy2.12332.

18.

Towards tailored vaccine delivery: needs, challenges and perspectives.

Amorij JP, Kersten GF, Saluja V, Tonnis WF, Hinrichs WL, Slütter B, Bal SM, Bouwstra JA, Huckriede A, Jiskoot W.

J Control Release. 2012 Jul 20;161(2):363-76. doi: 10.1016/j.jconrel.2011.12.039. Epub 2012 Jan 5. Review.

PMID:
22245687
19.

Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice.

Bal SM, Slütter B, Verheul R, Bouwstra JA, Jiskoot W.

Eur J Pharm Sci. 2012 Mar 12;45(4):475-81. doi: 10.1016/j.ejps.2011.10.003. Epub 2011 Oct 8.

PMID:
22009113
20.

Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination.

Verheul RJ, Slütter B, Bal SM, Bouwstra JA, Jiskoot W, Hennink WE.

J Control Release. 2011 Nov 30;156(1):46-52. doi: 10.1016/j.jconrel.2011.07.014. Epub 2011 Jul 20.

PMID:
21784113
21.

Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation.

Bal SM, Slütter B, Jiskoot W, Bouwstra JA.

Vaccine. 2011 May 23;29(23):4025-32. doi: 10.1016/j.vaccine.2011.03.039. Epub 2011 Mar 26.

PMID:
21443959
22.

Adjuvant effect of cationic liposomes and CpG depends on administration route.

Slütter B, Bal SM, Ding Z, Jiskoot W, Bouwstra JA.

J Control Release. 2011 Sep 5;154(2):123-30. doi: 10.1016/j.jconrel.2011.02.007. Epub 2011 Feb 21.

PMID:
21315779
23.

Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination.

Bal SM, Hortensius S, Ding Z, Jiskoot W, Bouwstra JA.

Vaccine. 2011 Jan 29;29(5):1045-52. doi: 10.1016/j.vaccine.2010.11.061. Epub 2010 Dec 1.

24.

Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?

Slütter B, Bal SM, Que I, Kaijzel E, Löwik C, Bouwstra J, Jiskoot W.

Mol Pharm. 2010 Dec 6;7(6):2207-15. doi: 10.1021/mp100210g. Epub 2010 Nov 2.

PMID:
21043518
25.

Advances in transcutaneous vaccine delivery: do all ways lead to Rome?

Bal SM, Ding Z, van Riet E, Jiskoot W, Bouwstra JA.

J Control Release. 2010 Dec 20;148(3):266-82. doi: 10.1016/j.jconrel.2010.09.018. Epub 2010 Sep 24. Review.

PMID:
20869998
26.

Influence of microneedle shape on the transport of a fluorescent dye into human skin in vivo.

Bal SM, Kruithof AC, Zwier R, Dietz E, Bouwstra JA, Lademann J, Meinke MC.

J Control Release. 2010 Oct 15;147(2):218-24. doi: 10.1016/j.jconrel.2010.07.104. Epub 2010 Jul 25.

PMID:
20650292
27.

Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations.

Bal SM, Ding Z, Kersten GF, Jiskoot W, Bouwstra JA.

Pharm Res. 2010 Sep;27(9):1837-47. doi: 10.1007/s11095-010-0182-y. Epub 2010 Jun 18.

28.

Transcutaneous immunization studies in mice using diphtheria toxoid-loaded vesicle formulations and a microneedle array.

Ding Z, Bal SM, Romeijn S, Kersten GF, Jiskoot W, Bouwstra JA.

Pharm Res. 2011 Jan;28(1):145-58. doi: 10.1007/s11095-010-0093-y. Epub 2010 Mar 17.

29.

Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations.

Bal SM, Slütter B, van Riet E, Kruithof AC, Ding Z, Kersten GF, Jiskoot W, Bouwstra JA.

J Control Release. 2010 Mar 19;142(3):374-83. doi: 10.1016/j.jconrel.2009.11.018. Epub 2009 Nov 22.

PMID:
19932723
30.

Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.

Bivas-Benita M, Lin MY, Bal SM, van Meijgaarden KE, Franken KL, Friggen AH, Junginger HE, Borchard G, Klein MR, Ottenhoff TH.

Vaccine. 2009 Jun 19;27(30):4010-7. doi: 10.1016/j.vaccine.2009.04.033. Epub 2009 May 3.

PMID:
19389445
31.

In vivo assessment of safety of microneedle arrays in human skin.

Bal SM, Caussin J, Pavel S, Bouwstra JA.

Eur J Pharm Sci. 2008 Oct 2;35(3):193-202. doi: 10.1016/j.ejps.2008.06.016. Epub 2008 Jul 8.

PMID:
18657610
32.

Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method.

Verbaan FJ, Bal SM, van den Berg DJ, Dijksman JA, van Hecke M, Verpoorten H, van den Berg A, Luttge R, Bouwstra JA.

J Control Release. 2008 May 22;128(1):80-8. doi: 10.1016/j.jconrel.2008.02.009. Epub 2008 Feb 26.

PMID:
18394741
33.

Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin.

Verbaan FJ, Bal SM, van den Berg DJ, Groenink WH, Verpoorten H, Lüttge R, Bouwstra JA.

J Control Release. 2007 Feb 12;117(2):238-45. Epub 2006 Nov 17.

PMID:
17196697

Supplemental Content

Support Center